Condition category
Skin and Connective Tissue Diseases
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status

Plain English Summary

Background and study aims
Gynoid lipodystrophy, also known as cellulite, is a very common skin alteration (such as dimples or bumpy) that is mainly a cosmetic concern rather than a real disease. For many people it is very concerning as they do not like the way it looks. Cellulite can be treated through lasers, liposuction (surgical procedure that removes fat) as well as topic treatments (such as creams). However, an effective treatment of cellulite has not been well established. The aim of this study is to evaluate the effect of an anti-cellulite cream on the appearance of cellulite on the thigh.

Who can participate?
Women aged 18 to 65 who have cellulite.

What does the study involve?
Participants are asked to apply a cream once daily for 60 days in the body area affect by cellulite (gluteal regions, thighs and buttock). Participants attend study visits one and two months after using the cream to measure their thigh circumference and have pictures taken of certain areas to assess their cellulite levels.

What are the possible benefits and risks of participating?
There are no notable benefits or risks with participating.

Where is the study run from?
This study is being run by Difa Cooper (Italy) and takes place in Medica Plus Modena Via Bernini Coordinator Centre (Italy) and private dermatology services in Naples (Italy)

When is the study starting and how long is it expected to run for?
September 2016 to June 2017

Who is funding the study?
Difa Cooper (Italy)

Who is the main contact?
Dr Massimo Milani

Trial website

Contact information



Primary contact

Dr Massimo Milani


Contact details

Difa Cooper
Via Milano 160
Caronno Perusella

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Efficacy of a novel hypertonic draining cream for cellulite reduction: a Clinical and instrumental (Antera 3D) assessment


Study hypothesis

The aim of this study is to evaluate the effect of an anticellulite cream on thigh circumference and skin profilometry assessed by Antera 3D.

Ethics approval

Medica Plus Service Modena, 20/10/2016

Study design

Interventional randomised controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type

Quality of life

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet


Gynoid lipodystrophy (Cellulite)


Participants are given an hypertonic topical product with draining action (HTC cream) that contains NaCl 13%, escine, caffeine and beta-sytosterol. They are asked to apply it once daily on their thighs, gluteal and buttock regions for 60 days.

Participants are assessed at baseline, one and two months to measure their thighs (this procedure is done by an evaluator (office clinic nurses) blinded to the type of treatment. Measurements are done with the participant standing and measuruing up to 25 cm from the superior pole of the patella.
Participant also undergo computer analysis of their skin to asses their cellulite levels at baseline and two months. The Antera 3D CS images system measures in an objective and operator-independent manner the volume of skin protrusions and depressions of a pre-specified area. Volume of depressions in the target zone are expressed in mm3.

Intervention type



Drug names

Primary outcome measure

1. Thigh circumferential is measured using a flexible measuring ruler with the participant in standing position and performing the measurement up to 25 cm from the superior pole of the patella at baseline, one and two months
2. Computer-analysis of skin profilometry of a pre-specified target area (in general in the zone above the trochanteric eminence or gluteal zone) evaluated by means of Antera 3D CS (Miravex, Dublin, Ireland) at baseline and two months

Secondary outcome measures

Cellulite (skin appearance) are measured using the orange peel severity score (0 to 5) before and after the pinch test at baseline, one and two months.

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Women aged 18-65 years
2. Have grade II-IV gynoid lipodystrophy

Participant type


Age group




Target number of participants


Participant exclusion criteria

1. Previous treatment (within 2 months of the study period) for cellulite (topical or oral)
2. Positive history for lower limbs venous or lymphatic insufficiency
3. Pregnancy or breast feeding
4. Positive history of allergic contact dermatitis to any of the component of the cream

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Medica Plus Modena Via Bernini Coordinator Centre

Trial participating centre

Private Dermatology Service Naples

Sponsor information


Difa Cooper

Sponsor details

Via Milano 160
Caronno Perusella

Sponsor type




Funder type


Funder name

Difa Cooper SpA

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Planned publication in a Pubmed Indexed international high-impact peer reviewed Journal by the end of October 2017.

IPD sharing statement:
The datasets generated during and/or analysed during the current study are/will be available upon request from Dr Massimo Milani. Data have been stored as Excel file.

Intention to publish date


Participant level data

Available on request

Basic results (scientific)

Publication list

2018 results in:

Publication citations

Additional files

Editorial Notes

11/07/2018: IPD sharing statement added. 10/07/2018: Publication reference added. 24/10/2017: Internal review 25/09/2017: Internal review